Cargando…

Prevalence of Sarcopenia and Impact on Survival in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours

SIMPLE SUMMARY: Neuroendocrine tumours are rare tumours arising in the digestive system, mainly the small bowel or pancreas. Due to their location in the digestive tract, NETs can cause symptoms of diarrhoea, abdominal pain or weight loss. These symptoms are often correlated with nutrition. Poor nut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clement, Dominique S. V. M., van Leerdam, Monique E., de Jong, Soraya, Weickert, Martin O., Ramage, John K., Tesselaar, Margot E. T., Srirajaskanthan, Rajaventhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913815/ https://www.ncbi.nlm.nih.gov/pubmed/36765740 http://dx.doi.org/10.3390/cancers15030782

Ejemplares similares

Nutritional and vitamin status in patients with neuroendocrine neoplasms
por: Clement, Dominique SVM, et al.
Publicado: (2019)

Feasibility of Home Parenteral Nutrition in Patients with Intestinal Failure Due to Neuroendocrine Tumours: A Systematic Review
por: Clement, Dominique S. V. M., et al.
Publicado: (2023)

Quality of life in patients with gastroenteropancreatic tumours: A systematic literature review
por: Watson, Catherine, et al.
Publicado: (2020)

A Multimodal Approach to the Management of Neuroendocrine Tumour Liver Metastases
por: Basuroy, Ron, et al.
Publicado: (2012)

Optimising Outcomes and Surveillance Strategies of Rectal Neuroendocrine Neoplasms
por: Srirajaskanthan, Rajaventhan, et al.
Publicado: (2023)

Posterior reversible encephalopathy syndrome in a patient with a metastatic pancreatic neuroendocrine tumour and ectopic Cushing’s syndrome
por: Palmer, Kieran, et al.
Publicado: (2021)

ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours
por: Srirajaskanthan, Rajaventhan, et al.
Publicado: (2013)

Sarcopenia and Ghrelin System in the Clinical Outcome and Prognosis of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Herrera-Martínez, Yiraldine, et al.
Publicado: (2021)

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
por: Ramage, John K, et al.
Publicado: (2011)

Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours
por: Ahn, H K, et al.
Publicado: (2013)

Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decade
por: Kooyker, Arthur I, et al.
Publicado: (2019)

Efficacy and safety of (177)Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study
por: Clement, Dominique, et al.
Publicado: (2022)

Delays and routes to diagnosis of neuroendocrine tumours
por: Basuroy, Ron, et al.
Publicado: (2018)

Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study
por: White, Benjamin E., et al.
Publicado: (2022)

Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012–2018: A Retrospective, Population-Based Study
por: White, Benjamin E., et al.
Publicado: (2023)

Diagnostic features and management options for duodenal neuroendocrine neoplasms: a retrospective, multi-centre study
por: Mandair, Dalvinder, et al.
Publicado: (2022)

Second Primary Malignancies in Patients with a Neuroendocrine Neoplasm in England
por: Russell, Beth, et al.
Publicado: (2023)

Mesenteric Variceal Haemorrhage and Ectopic Cushing's Syndrome as Presenting Features of a Pancreatic Neuroendocrine Tumour Recurrence
por: Weerasuriya, Scott, et al.
Publicado: (2021)

Liver metastases in gastroenteropancreatic neuroendocrine tumours – treatment methods
por: Gut, Paweł
Publicado: (2020)

The Multidisciplinary Team for Gastroenteropancreatic Neuroendocrine Tumours: The Radiologist’s Challenge
por: Granata, Vincenza, et al.
Publicado: (2019)

Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets
por: Aristizabal Prada, E T, et al.
Publicado: (2017)

The role of serotonin inhibition within the treatment of carcinoid syndrome
por: George, Joel, et al.
Publicado: (2023)

Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours
por: Mills, Logan, et al.
Publicado: (2017)

Patient-reported health state utilities in metastatic gastroenteropancreatic neuroendocrine tumours – an analysis based on the CLARINET study
por: Meng, Yang, et al.
Publicado: (2017)

Cost‐of‐illness of metastatic gastroenteropancreatic neuroendocrine tumours in Sweden—A population‐based register‐linkage study
por: Lesén, Eva, et al.
Publicado: (2019)

First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
por: Bongiovanni, Alberto, et al.
Publicado: (2015)

NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance
por: van Treijen, Mark J C, et al.
Publicado: (2022)

Gastroenteropancreatic neuroendocrine tumour arising in Meckel’s diverticulum coexisting with colon adenocarcinoma
por: Katalinic, Darko, et al.
Publicado: (2014)

Radioguided Surgery for Gastroenteropancreatic Neuroendocrine Tumours: a Systematic Literature Review
por: Cockburn, Katrina Clair, et al.
Publicado: (2021)

Tumour Heterogeneity and the Consequent Practical Challenges in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Reccia, Isabella, et al.
Publicado: (2023)

Human Immunocompetent Model of Neuroendocrine Liver Metastases Recapitulates Patient-Specific Tumour Microenvironment
por: Doornebal, Ewald Jan, et al.
Publicado: (2022)

Epidemiologic trends and survival of early-onset gastroenteropancreatic neuroendocrine neoplasms
por: Yao, Hailing, et al.
Publicado: (2023)

Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm
por: Shi, Huiying, et al.
Publicado: (2020)

Calcitonin-secreting neuroendocrine neoplasms of the lung: a systematic review and narrative synthesis
por: Llewellyn, David C, et al.
Publicado: (2021)

Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives
por: Appetecchia, Marialuisa, et al.
Publicado: (2010)

Survival in Patients with Neuroendocrine Tumours of the Small Intestine: Nomogram Validation and Predictors of Survival
por: Levy, Sonja, et al.
Publicado: (2020)

Goblet Cell Adenocarcinoma of the Appendix: A Systematic Review and Incidence and Survival of 1,225 Cases From an English Cancer Registry
por: Palmer, Kieran, et al.
Publicado: (2022)

Treatment Patterns and Survival among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours in Sweden - a Population-based Register-linkage and Medical Chart Review Study
por: Lesén, Eva, et al.
Publicado: (2019)

Matching-adjusted indirect treatment comparison of [(177)Lu]Lu-DOTA-TATE, everolimus and sunitinib in advanced, unresectable gastroenteropancreatic neuroendocrine tumours: Relative effectiveness of [(177)Lu]Lu-DOTA-TATE in gastroenteropancreatic neuroendocrine tumours
por: Khan, Mohid S., et al.
Publicado: (2021)

Advances in the treatment of gastroenteropancreatic neuroendocrine tumors
por: Kunz, Pamela L, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ic2vcm2rvo4sqgcgkui92pfhk9